Connect with us

Sci/tech

Indian scientists ace 1st human clinical trial of haemophilia A gene therapy

Published

on

New Delhi, Feb 28 (IANS) Scientists at the Christian Medical College (CMC) Vellore have successfully conducted the country’s first human clinical trial of gene therapy for haemophilia A (FVIII deficiency), Union Minister Dr. Jitendra Singh said on Wednesday. He said this while addressing the “National Science Day 2024” programme at Vigyan Bhawan here.

Hemophilia A is a genetic disorder caused by missing or defective factor VIII (FVIII), a clotting protein, which means the patient bleeds longer than others.

The clinical trials involved deploying a novel technology of using a lentiviral vector to express a FVIII transgene in the patient’s own haematopoietic stem cell, which will then express FVIII from specific differentiated blood cells.

India is home to the second-largest population of patients living with Haemophilia, with an estimated 1,36,000 individuals grappling with hemophilia A.

However, only around 21,000 are registered at present.

About 80 per cent of hemophilia cases go undiagnosed in India as several hospitals and medical institutions lack screening capabilities for blood clotting, affecting the diagnosis of new cases. “The manufacturing of this vector will commence soon in India and proceed with further clinical trials,” the minister said.

ALSO READ:  Adani Wilmar clocks 67 per cent surge in PAT for FY24, gains market share across key products

The trial was supported by the Department of Biotechnology, the Centre for Stem Cell Research — a unit of InStem Bengaluru, in collaboration with Emory University, US at Christian Medical College, Vellore.

In about 80 per cent cases, haemophilia manifests as bleeding, most frequently involving the large joints like knees, ankles, elbows, hip and wrist, followed by deep bleeds affecting large body muscles.

However, the most dangerous ones are bleeds affecting the head/brain, neck, chest cavity and abdominal and pelvic cavity.

–IANS

rvt/pgh

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Sci/tech

Indian startups raised nearly $176 million across 16 deals in July 1st week

Published

on

By

New Delhi, July 6 (IANS) The Indian startup ecosystem raised nearly $176 million in funding across 16 deals in the first week of this month.

In the biggest funding round, fashion e-commerce platform Purplle secured $120 million led by Abu Dhabi Investment Authority.

Agri-tech startup Arya.ag also announced to raise $29 million led by impact investment firm Blue Earth Capital.

Video telematics startup Cautio also announced a pre-seed raise of Rs 6.5 crore led by Antler, 8i Ventures and AU Small Finance Bank.

Homegrown startups have raised nearly $7 billion in funding during the first half (H1) of 2024, more than the $5.92 billion raised in H1 2023.

Also, the fintech ecosystem achieved a significant milestone in the first half of this year by ranking among the top three funded globally, alongside the US and the UK.

–IANS

na/uk

ALSO READ:  3 in 4 feature phone users in India consider switching to smartphones: Study
Continue Reading

Sci/tech

Facing unexplainable mood disorders? You may be low on Vitamin B 12: Doctors

Published

on

By

New Delhi, July 6 (IANS) Vitamin B-12 plays a key role in producing brain chemicals that affect mood and other brain functions, said doctors on Saturday.

Vitamin B-12 (also known as cobalamin) plays a crucial role in the formation of red blood cells, cell metabolism, nerve function, and the production of DNA.

Some common symptoms of Vitamin B12 deficiency include strange sensations, numbness, or tingling in the hands, legs, or feet, difficulty walking (staggering, balance problems), anaemia, difficulty thinking and reasoning (cognitive difficulties), memory loss, weakness, or fatigue.

“Vitamin B-12 and other B vitamins play a crucial role in producing brain chemicals that affect mood and other brain functions. Low levels of B-12, as well as other B vitamins like vitamin B-6 and folate, may be linked to depression,” Dr Anshu Rohtagi, Senior Consultant, Department of Neurology, Sir Ganga Ram Hospital, told IANS.

“The deficiencies can result from poor diet or difficulties in absorbing the vitamins consumed. So, maintaining adequate B-12 level is essential for overall well-being, including mood regulation,” she added.

ALSO READ:  Water tech major Wabag secures Rs 85 crore order for Oman desalination plant

Vitamin B-12 is majorly found in poultry, meat, fish, and dairy products. It is available as an oral supplement, as injections, or nasal spray.

People who consume a vegetarian or vegan diet may be more prone to deficiency as plant foods do not contain vitamin B-12. The elderly and people with digestive tract conditions that affect the absorption of nutrients also are susceptible to vitamin B-12 deficiency.

“Vitamin B12 plays a crucial role in producing brain chemicals like serotonin, which helps regulate mood. When B12 levels dip, these chemicals can become imbalanced, potentially leading to symptoms like mood swings, irritability, and even depression,” Dr Guruprasad Hosurkar, Additional Director – Neurology, Fortis Hospital, Bannerghatta Road, Bengaluru, told IANS.

Importantly, the doctor explained that the “connection is not gender-specific. Both men and women can experience mood changes due to B12 deficiency”.

While research is ongoing, studies suggest a link between low B12 and depression, with some showing improvement in mood with B12 supplementation.

ALSO READ:  New research shows walking can stop backache from returning

However, it’s important to note that mood swings can have many causes, and a doctor should be consulted to rule out other factors and determine if a B12 deficiency is present, Dr Guruprasad said.

“Vitamin B12 deficiency causes several neurological symptoms such as tingling, numbness & burning of feet, imbalance, memory impairment, mood disorders, psychosis, seizures, and Parkinsonism,” explained Dr Sudhir Kumar, from Indraprastha Apollo Hospitals, Hyderabad in a post on social media platform X.

“In a patient presenting with neurological or psychiatric symptoms, suspect vitamin B12 deficiency as a cause (especially if there is no obvious cause identified). Early diagnosis and prompt initiation of treatment rapidly improves patient’s symptoms,” he added.

The doctors also stressed the need to maintain a healthy lifestyle and advised key behaviours such as managing high blood pressure, and blood sugar, quitting smoking, and alcohol, staying physically active, getting adequate sleep, and managing stress.

–IANS

rvt/uk

Continue Reading

Sci/tech

Former NASA astronaut Steve Lee Smith to headline Kerala AI conclave

Published

on

By

Kochi, July 6 (IANS) Former NASA astronaut and technology executive Steve Lee Smith will be the highlight of the two-day first International GenAI Conclave to be hosted by the Kerala Government in Kochi on July 11 and 12.

This event is in association with IBM. Chief Minister Pinarayi Vijayan will inaugurate it.

A veteran astronaut, Smith flew into space four times at 28,000 KMH on the space shuttle during his stint in NASA, covering 16 million miles.

He also performed seven spacewalks, including repairs of the Hubble Space Telescope.

Smith will speak on ‘Lessons Learned from A Skywalker’ at the conclave.

The event will be attended by leading lights in this area to explore the transformative potential of AI and its impact on society and the economy.

The GenAI conclave aims to transform Kerala as an AI destination and showcase the state’s perspectives on industry 4.0, besides giving a thrust to the growth of the economy.

ALSO READ:  Not just startups, Big Tech firms also opposed to fair-share demand from telcos: COAI

Besides developers, universities, students, media and analysts, the conclave will feature demos, activations, interactions with industry experts, panel discussions and lectures.

Participants will also get a first-hand experience in the latest advancements in the AI sector.

–IANS

sg/kvd

Continue Reading

Sci/tech

Mice with functional humanised immune system shows promise

Published

on

By

New Delhi, July 6 (IANS) A first-of-its-kind mice model with a fully functional human immune system and a human-like gut microbiome has shown promise of mounting specific antibody responses.

To date, researchers have not developed a fully functional human immune system, but only those with a brief lifespan that do not mount efficient immune responses, making them unsuitable for the development of in vivo human immunotherapies, human disease modelling, or human vaccine development.

Developed by scientists at The University of Texas in the US, the new model will overcome limitations of currently available in vivo human models and is a breakthrough for biomedical research and promises new insight into immunotherapy development and disease modelling.

Detailed in the journal Nature Immunology, the new humanised mice, called TruHuX (for truly human, or THX), possess a fully developed and fully functional human immune system, including lymph nodes, germinal centres, thymus human epithelial cells, human T and B lymphocytes, memory B lymphocytes, and plasma cells making highly specific antibody and autoantibodies identical to those of humans.

ALSO READ:  Adani Wilmar clocks 67 per cent surge in PAT for FY24, gains market share across key products

THX mice mount mature neutralising antibody responses to Salmonella Typhimurium and SARS-CoV-2 virus Spike S1 RBD after vaccination with Salmonella flagellin and the Pfizer Covid-19 mRNA vaccine, respectively.

It is also amenable to developing full-fledged systemic lupus autoimmunity after an injection of pristane — an oil that triggers an inflammatory response.

“THX mice provide a platform for human immune system studies, development of human vaccines, and testing of therapeutics,” said Paolo Casali, Professor at the University of Texas School of Medicine in San Antonio, US.

They do this “by critically leveraging oestrogen activity to support human stem cell and human immune cell differentiation and antibody responses”, he added.

–IANS

rvt/svn

Continue Reading

Sci/tech

Atal Innovation Mission empowering innovators in Tier 2 & 3 cities: Director

Published

on

By

New Delhi, July 6 (IANS) Atal Innovation Mission’s (AIM) Community Innovator Fellows (CIFs) programme is empowering innovators in Tier 2 and Tier 3 cities, said Dr. Chintan Vaishnav, Mission Director at AIM.

He said this while delivering a keynote address at NITI Aayog marking the celebration of the graduation of its second batch of CIFs on Friday.

Dr. Chintan underscored the programme’s pivotal role in advancing solutions across healthcare, education, agriculture, and financial services, resonating deeply with the ethos of sustainable development.

“We have now established robust institutions that seamlessly integrate business incubation with academia. This well-designed project aspires to be a model of excellence,” Dr. Vaishnav said.

He noted that the Community Innovator initiative “captures the aspirations of youth eager to go beyond traditional boundaries in innovation and startups. It embodies both rigour and relevance, truly inspiring in its mission and impact.”

AIM, through its Atal Community Innovation Centres (ACIC) programme has envisaged serving the unserved/underserved areas of the country, providing support to every grassroots innovator, and working towards accelerating the pathway to reach SDGs 2030.

ALSO READ:  New research shows walking can stop backache from returning

“These innovators serve as role models not only for their communities but also for society at large. I’m delighted to witness each business prospering — it’s like shaping raw gold into a precious jewel,” said Anurag Pratap Singh, Vice President & CSR Leader at Capgemini India.

Dr. Suresh Reddy, Lead CSR & Director at SRF Foundation, reflected on the impact of social entrepreneurship in addressing community challenges.

–IANS

rvt/rad

Continue Reading

Trending